Skip to main content
SONOSCAPE MEDICAL CORP. logo

SONOSCAPE MEDICAL CORP. — Investor Relations & Filings

Ticker · 300633 ISIN · CNE100002P91 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 1,204 across all filing types
Latest filing 2025-12-11 Governance Information
Country CN China
Listing Shenzhen Stock Exchange 300633

About SONOSCAPE MEDICAL CORP.

https://www.sonoscape.com

SonoScape Medical Corp. specializes in the research, development, and manufacturing of advanced medical diagnostic equipment. The company's primary product portfolio includes high-definition ultrasound systems, flexible endoscopy solutions, and electrocardiography devices. SonoScape focuses on delivering innovative imaging technology to healthcare providers globally, ranging from portable diagnostic tools to comprehensive trolley-based systems. Their ultrasound range covers various clinical applications such as cardiology, obstetrics, and radiology, while their endoscopy division provides high-resolution video processors and scopes for gastrointestinal and respiratory procedures. The company emphasizes continuous technological advancement and clinical efficiency to improve patient outcomes and diagnostic accuracy in diverse medical settings.

Recent filings

Filing Released Lang Actions
信息披露暂缓与豁免管理制度
Governance Information Classification · 95% confidence The document is titled '信息披露暂缓与豁免管理制度' which translates to 'Information Disclosure Delay and Exemption Management System' issued by Shenzhen Kaili Biomedical Technology Co., Ltd. It outlines internal policies and procedures regarding the delay and exemption of information disclosure, including definitions, scope, management, approval processes, and responsibilities. The content is regulatory and governance-related, focusing on compliance with disclosure laws and internal controls rather than financial results or shareholder meeting materials. The document is relatively short (3664 characters) and does not contain financial statements, earnings data, or voting results. It is not an announcement of a report but a governance policy document. Therefore, the most appropriate classification is Governance Information (CGR).
2025-12-11 Chinese
关于部分募集资金投资项目延期的公告
Capital/Financing Update Classification · 95% confidence The document is an official announcement from Shenzhen Kaili Biomedical Technology Co., Ltd. regarding the delay of certain fundraising investment projects. It details the background of the fundraising, the amounts raised, the progress of the projects, reasons for the delay, and approvals from the board and supervisory committee. The document references regulatory compliance with Shenzhen Stock Exchange rules and the China Securities Regulatory Commission approvals. It does not contain financial statements or detailed financial performance data but focuses on the status and changes related to the use of raised funds. The document length is 4577 characters, which is relatively short and reads as an announcement rather than a full report. This fits the profile of a Capital/Financing Update (CAP) as it updates investors on the status of capital raised and its deployment, specifically the delay in investment projects funded by the raised capital. It is not an Annual Report, Interim Report, or Earnings Release, nor is it a regulatory filing or report publication announcement. Therefore, the best classification is Capital/Financing Update (CAP).
2025-12-11 Chinese
董事会战略与可持续发展委员会工作细则
Governance Information Classification · 95% confidence The document is titled '董事会战略与可持续发展委员会工作细则' which translates to 'Board Strategic and Sustainable Development Committee Working Rules'. It details the establishment, composition, responsibilities, decision-making procedures, and meeting rules of a board committee focused on strategy and sustainability. There are no financial statements, earnings data, or regulatory filings. The document is a governance-related internal rules document describing board committee structure and functions. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document length is 2601 characters, consistent with a detailed governance policy document rather than a brief announcement or a full annual report.
2025-12-11 Chinese
对外担保管理制度
Governance Information Classification · 95% confidence The document is titled '深圳开立生物医疗科技股份有限公司 对外担保管理制度' which translates to 'Shenzhen Kaile Biomedical Technology Co., Ltd. External Guarantee Management System'. It is a detailed internal management system document outlining the company's policies, procedures, and responsibilities regarding external guarantees (担保). The content includes definitions, approval procedures, management responsibilities, legal liabilities, and compliance with relevant laws and regulations. There is no indication that this is a financial report, audit, earnings release, or any form of shareholder meeting material. It is not a regulatory announcement or a report publication announcement. Instead, it is a governance-related document detailing internal rules and management practices related to external guarantees. Therefore, the most appropriate classification is Governance Information (CGR). The document length (6230 characters) and detailed procedural content support this classification with high confidence.
2025-12-11 Chinese
互动易平台信息发布及回复内部审核制度
Governance Information Classification · 95% confidence The document is titled '互动易平台信息发布及回复内部审核制度' which translates to 'Internal Review System for Information Release and Response on the Interactive Platform'. It outlines internal policies and procedures for managing investor communications via an interactive platform, including compliance with regulatory disclosure rules and internal approval processes. There is no financial data, no report of financial results, no announcement of voting results, no management changes, no legal proceedings, no capital changes, and no earnings or annual report content. The document is a governance-related internal policy document focused on investor relations and information disclosure management. Therefore, it fits best under Governance Information (CGR). The document length is 2484 characters, which is relatively short but contains substantive policy content rather than a mere announcement or certification, so it is not RPA or RNS. Confidence is high given the clear focus on governance and internal control procedures for information disclosure.
2025-12-11 Chinese
薪酬管理制度
Remuneration Information Classification · 95% confidence The document is titled '薪酬管理制度' which translates to 'Compensation Management System' or 'Remuneration Management System'. It details the company's policies and procedures regarding employee and executive compensation, including salary determination, performance pay, long-term incentives, and related governance. It references the company's board and shareholder meetings for approval of remuneration plans. The content is focused on remuneration policies rather than actual compensation figures or financial results. This matches the description of a Remuneration Information report, which details compensation for top executives and directors. The document length is 3020 characters, which is sufficient for a policy document but not a brief announcement. Therefore, the appropriate classification is Remuneration Information (DEF 14A).
2025-12-11 Chinese

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.